Selective IL-13 inhibitors for the treatment of atopic dermatitis

BACKGROUND: Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases worldwide. AD pathogenesis is multifactorial, involving environmental and genetic factors. IL-13 stands out as one of the main cytokines in the pathophysiology of AD. Currently, dupilumab, which targets b...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonçalves, Francisca, Freitas, Egídio, Torres, Tiago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015935/
https://www.ncbi.nlm.nih.gov/pubmed/33889195
http://dx.doi.org/10.7573/dic.2021-1-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015935/
https://www.ncbi.nlm.nih.gov/pubmed/33889195
http://dx.doi.org/10.7573/dic.2021-1-7

Ejemplares similares